Seeking Alpha

forever5683

forever5683
Send Message
View as an RSS Feed
View forever5683's Comments BY TICKER:
Latest  |  Highest rated
  • Fannie and Freddie chiefs get $3.4M raises [View news story]
    Of course, Nope, it makes no sense. Still it's GSE, not a private company. He makes more than our president. LOL. I'm sure there's some CEO who would like to make $600K/annually and can do same or better job than the current CEO.

    This raise makes no sense because GSE owes the company. They don't have to nor need to raise the his salary.
    Jul 1, 2015. 03:33 PM | 1 Like Like |Link to Comment
  • Apricus Biosciences And Vivus: A Potential Golden Marriage [View article]
    I liked it, BUT APRI is still better and has a better potential reward in the future even without VVUS. VVUS, on the hand, has a huge amount of debt at the same time.
    If they ought to merge, APRI share holders should be awarded back.

    APRI has three strong pipelines underway and currently, one of their drug is on sale.

    APRI has a good sourceS of income, recently acquired partners in Spain and France, France will be a good income source. Canada, once the acquisition settles, will be another good source of income. APRI is also looking for a way to sell their drug in asia.

    APRI wouldn't need to dilute shares RIGHT AWAY in order to fund their pipelines. APRI is getting royalties and milestones payments from their partner. Dilution may not be needed at all, or just it may only need to dilute bit one time.

    If one of three pipelines approved, they may get a better acquisition by a big pharm.
    Jun 16, 2015. 07:22 PM | 2 Likes Like |Link to Comment
  • Premarket Gainers / Losers as of 9:15 am [View news story]
    $OXGN is just the beginning.
    Jun 1, 2015. 12:32 PM | Likes Like |Link to Comment
  • New chief at OXiGENE [View news story]
    i am pretty sure
    May 12, 2015. 06:22 PM | Likes Like |Link to Comment
  • New chief at OXiGENE [View news story]
    This man sold CHTP last year. Hope he does same thing with OXGN,
    I've seen a high price target of $19.
    May 12, 2015. 04:48 PM | Likes Like |Link to Comment
  • IsoRay's Cesium-131 Long Awaited Lung Study Results Appear To Be Coming May 8th [View article]
    No body knows ,
    CNAT, before their approval, their stock soared from $8 to $14 , BUT their FDA failed them on the date of announcement, it plunged to $6 .

    DRTX their stock dropped after their approval, It didn't even increased that much from $12 to $14 on the date of FDA approval. And it dropped as usual after the FDA. The price stayed between $10 ~ $15 , then 4 months later, it was bought Out for $24.

    What I know is some of directors are anticipating on this May 8th .
    Apr 29, 2015. 02:35 PM | Likes Like |Link to Comment
  • IsoRay's Cesium-131 Long Awaited Lung Study Results Appear To Be Coming May 8th [View article]
    no body knows of perfect timing of getting it.
    insiders already have been buying up their shares.
    Apr 29, 2015. 02:31 PM | 1 Like Like |Link to Comment
  • Apricus Biosciences Is Executing Its Strategic Plans [View article]
    @tpchiphx I do think APRI is a possible BuyOut target.
    Apr 21, 2015. 11:24 AM | Likes Like |Link to Comment
  • Celldex teams up with Roche in cancer immunotherapy trial [View news story]
    buy on rumor , sell on good news
    Mar 17, 2015. 12:40 PM | 3 Likes Like |Link to Comment
  • MannKind: Use This Drop As An Opportunity [View article]
    SEE, it's now even $5.50 close to low $5s.
    I bought half of what I was going to get and get rest if it drops further below. If you can get under $5, that's fantastic.
    Here, I learned from S ... A.. that Don't listen to contributor.
    Mar 6, 2015. 09:53 AM | Likes Like |Link to Comment
  • MannKind: Use This Drop As An Opportunity [View article]
    yes, you can get MNKD in low $5s. After Goldman sliced its target price to $3, it's very possible.
    Mar 4, 2015. 09:03 AM | 2 Likes Like |Link to Comment
  • Institutions Lend Out MannKind Shares To Make Profits But Depress The Price As Well [View article]
    " As you can see from the chart below, MannKind has always had a large amount of short interest. But, it has continued to grow, even after approval of Afrezza. "

    I think MNKD was rose recently due to its earning report; Some people were hoping or expecting some news or some profit from Afreeza.
    The chart isn't actually growing in this case; It's just the shorts making money from this. The range, it should be $5~$6 for next two months, will start climbing up as the first Afreeza revenue would be reported.
    Hope it's good or show a chance of its success or it would be sliced again to $3 range.
    Mar 2, 2015. 12:54 PM | 2 Likes Like |Link to Comment
  • Achillion Pharma initiates equity offering [View news story]
    @Deputy Zaine LOL ~
    Feb 10, 2015. 05:02 PM | Likes Like |Link to Comment
  • Is Conatus Poised For A Breakout? [View article]
    and dropped 4.5% after hour.
    Jan 7, 2015. 01:12 AM | Likes Like |Link to Comment
  • GT Advanced asks for approval to pay millions in exec bonuses [View news story]
    LOL what a comedy ~
    Dec 31, 2014. 01:24 PM | 1 Like Like |Link to Comment
COMMENTS STATS
121 Comments
106 Likes